Helix BioPharma Company (PK) (HBPCF)
USOTC
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current HBPCF market cap is 44.82M. The company's latest EPS is CAD -0.1283 and P/E is -9.35.
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.49M | -8.62M | -9.13M | -5.87M | -6.22M |
| Net Income | -7.53M | -9.17M | -8.04M | -6.56M | -6.29M |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 940k | 4.91M | 4.07M | 3.73M | 1.03M |
| Total Liabilities | 4.22M | 1.93M | 5.46M | 3.41M | 1.87M |
| Total Equity | -3.28M | 2.98M | -1.39M | 319k | -844k |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -5.53M | -10.83M | -9.3M | -6.51M | -5.53M |
| Investing | -4k | 1.7M | 2.02M | N/A | -5k |
| Financing | 5.41M | 13.1M | 6.56M | 6.21M | 3.09M |
| Market Cap | 44.82M |
| Price to Earnings Ratio | -9.35 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 72.73 |
| Price to Book Ratio | -69.7 |
| Dividend Yield | - |
| Shares Outstanding | 49.02M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 29.41% |
| 52 Week High | 0.831 |
| 52 Week Low | 0.6885 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Helix BioPharma Company (PK) |
| Address |
2704, 401 bay street toronto, ontario M5H 2Y4 |
| Website | https://www.helixbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
